Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Healthcare & Life Sciences Private Equity Deal Tracker: Linden and Audax Invest in StatLab Medical Products

Posted in Healthcare Services Investing

Linden Capital Partners and Audax Private Equity have invested in StatLab Medical Products, according to a news release.

StatLab, based in McKinney, Texas, is a manufacturer and distributor of consumables, reagents and equipment used by anatomic pathology, molecular diagnostics and other laboratories. Founded in 1976, the company provides more than 5,000 diagnostic products and equipment.

Linden, based in Chicago, is a private equity firm focused exclusively on the healthcare industry. Founded in 2004, the firm pursues acquisition opportunities across the healthcare industry, including services, products and distribution companies, and prefers to make more substantial investments from a dollars perspective.

Audax, with private equity offices in Boston, New York and San Francisco, focuses on investments in middle market companies and has a wide flexibility on investment size. Founded in 1999, the firm targets companies within healthcare and several other industries, specifically those generating between $10 million and $50 million in annual EBITDA.

Terms of the investment were not disclosed.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.